Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity

European Journal of Neuroscience

Volumn 17, Issue 7, 2003, Pages 1403-1410

  Bymaster, Frank P ^a   Carter, Petra A ^a   Yamada, Masahisa ^b   Gomeza, Jesus ^b   Wess, Jürgen ^b   Hamilton, Susan E ^c   Nathanson, Neil M ^c   McKinzie, David L ^a   Felder, Christian C ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acetylcholine; Knockout mice; Muscarinic M1 receptors; Muscarinic M2 receptors; Muscarinic receptors

Indexed keywords

MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; OXOTREMORINE; PHOSPHATIDYLINOSITIDE; PILOCARPINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; HIPPOCAMPUS; HYPOTHERMIA; KNOCKOUT MOUSE; LETHAL DOSE; LETHALITY; LIPID HYDROLYSIS; MALE; MOUSE; MYDRIASIS; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SALIVATION; SEIZURE; TREMOR; WILD TYPE;

ANIMALS; APOMORPHINE; BODY TEMPERATURE; CEREBRAL CORTEX; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENOTYPE; HIPPOCAMPUS; HYDROLYSIS; HYPOTHERMIA; LITHIUM; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; OXOTREMORINE; PARASYMPATHETIC NERVOUS SYSTEM; PHOSPHATIDYLINOSITOLS; PILOCARPINE; PUPIL; RECEPTORS, MUSCARINIC; SALIVATION; SEIZURES;

EID: 0037691865     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02588.x     Document Type: Article

References (48)

1. 1 receptor knockout mice. Soc. Neurosci. Abstract., 26, 1509.
2. Bartus, R.T., Dean, R.L., Beer, B. & Lippa, A.S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-414.
3. 1 Muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Mol. Cell. Neurosci., 18, 512-524.
4. Bymaster, F.P., Calligaro, D.O., Falcone, J.F., Marsh, R.D., Moore, N.A., Tye, N.C., Seeman, P. & Wong, D.T. (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology, 14, 87-96.
5. Bymaster, F.P., Carter, P.A., DeLapp, N.W., Calligaro, D.O. & Felder, C.C. (2001) Receptor reserve of PI-coupled muscarinic receptors in mouse hippocampus in vivo. Brain Res., 916, 165-171.
6. Bymaster, F.P., Carter, P.A., Peters, S.C., Zhang, W., Ward, J.S., Mitch, C.H., Calligaro, D.O., Whitesitt, C.A., DeLapp, N.W., Shannon, H.E., Rimvall, K., Jeppesen, L., Sheardown, M.J., Fink-Jensen, A. & Sauerberg, P. (1998) Xanome-line compared to other muscarinic agents on stimulation of PI hydrolysis in vivo and other cholinomimetic effects. Brain Res., 795, 179-190.
7. Bymaster, F.P., Heath, I., Hendricks, J. & Shannon, H.E. (1993) Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J. Pharmacol. Exp. Ther., 267, 16-24.
8. Bymaster, F.P., Shannon, H.E., Rasmussen, K., DeLapp, N.W., Ward, J.S., Calligaro, D.O., Mitch, C.H., Whitesitt, C., Ludvigsen, T.S., Sheardown, M., Swedberg, M., Rasmussen, T., Olesen, P.H., Jeppesen, L., Sauerberg, P. & Fink-Jensen, A. (1999) Potential role of muscarinic receptors in schizophrenia. Life Sci., 64, 527-534.
9. Coyle, J.T., Price, D.L. & Delong, M.R. (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science, 219, 1184-1190.
10. Dai, Y.S., Ambudkar, I.S., Horn, V.J., Yeh, C.K., Kousvelari, E.E., Wall, S.J., Li, M., Yasuda, R.P., Wolfe, B.B. & Baum, B.J. (1991) Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am. J. Physiol., 261, C1063-C1073.
11. Di Chiara, G., Morelli, M. & Consolo, S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci., 17, 228-233.
12. Doods, H.N., Mathy, M., Davidesko, D., van Charldorp, K.J., de Jonge, A. & van Zwieten, P.A. (1987) Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2, M3 receptors. J. Pharmacol. Exp. Ther., 242, 257-262.
13. Drachman, D.A. (1977) Memory and cognitive function in man: does the cholinergic system have a specific role. Neurology, 27, 783-790.
14. Eglen, R.M., Choppin, A., Dillon, M.P. & Hegde, S. (1999) Muscarinic receptor ligands and their therapeutic potential. Curr. Opin. Chem. Biol., 3, 426-432.
15. Felder, C.C. (1995) Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J., 9, 619-625.
16. Felder, C.C., Bymaster, F.P., Ward, J. & DeLapp, N. (2000) Therapeutic opportunities for muscarinic receptors in the central nervous system. J. Med. Chem., 43, 4333-4353.
17. Felder, C.C., Porter, A.C., Skillman, T.L., Zhang, L., Bymaster, F.P., Nathanson, N.M.,Hamilton,S.E.,Gomeza,J.,Wess,J.&McKinzie,D.L.(2001)Elucidating the role of muscarinic receptors in psychosis. Life Sci., 68, 2605-2613.
18. Fisahn, A., Yamada, M., Duttaroy, A., Gan, J.-W., Deng, C.-X., McBain, C.J. & Wess, J. (2002) Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation channels. Neuron, 14, 615-624.
19. Gerber, D.J., Sotnikova, T.D., Gainetdinov, R.R., Huang, S.H. & Caron, M.G. (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc. Natl Acad. Sci. USA, 98, 15312-15317.
20. Giacobini, E. (1997) Alzheimer disease, from molecular biology to therapy. Adv. Exp. Med. Biol., 429, 235-245.
21. Gil, D.W., Krauss, H.A., Bogardus, A.M. & WoldeMussie, E. (1997) Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest. Ophthalmol. Vis. Sci., 38, 1434-1442.
22. Gomeza, J., Shannon, H.E., Kostenis, E., Felder, C., Zhang, L., Brodkin, J., Grinberg, A., Sheng, H. & Wess, J. (1999a) Pronounced pharmacological deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc. Natl Acad. Sci. USA, 96, 1692-1697.
23. 4 muscarinic acetylcholine receptor knockout mice. Proc. Natl Acad. USA, 96, 10483-10488.
24. Greene, S.J., Felder, C.C., Hamilton, S.E., Nathanson, N.M. & Gannon, K.S. (2001) Analyses of spatial learning and activity in muscarinic M1 receptor knockout mice: Evidence for a cognitive deficit. Soc. Neurosci. Abstr., 27, 79.12.
25. Hagan, J.J., van der Heijden, B. & Broekkamp, C.L. (1988) The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine. Naunyn Schmiedebergs Arch. Pharmacol., 338, 476-483.
26. Hamilton, S.E., Loose, M.D., Qi, M., Levey, A.I., Hille, B., McKnight, G.S., Idzerda, R.L. & Nathanson, N.M. (1997) Disruption of the M1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc. Natl Acad. Sci. USA, 94, 13311-13316.
27. 1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J. Biol. Chem., 276, 15850-15853.
28. Ishizaka, N., Noda, M., Yokoyama, S., Kawasaki, K., Yamamoto, M. & Higashida, H. (1998) Muscarinic acetylcholine receptor subtypes in the human iris. Brain Res., 787, 344-347.
29. Iwabuchi, Y. & Masuhara, T. (1992) Subtype of the muscarinic receptor that mediates salivary secretion in the rat sublingual gland. Asia Pacific J. Pharmacol., 7, 197-202.
30. Jope, R.S., Morrisett, R.A. & Snead, O.C. (1986) Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp. Neurol., 91, 471-480.
31. Levey, A.I. (1993) Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci., 52, 441-448.
32. Marino, M.J., Rouse, S.T., Levey, A.I., Potter, L.T. & Conn, P.J. (1998) Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc. Natl Acad. Sci. USA, 95, 11465-11470.
33. Markram, H. & Segal, M. (1992) The inositol 1,4,5-trisphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA. J. Physiol. (Lond.), 447, 513-533.
34. Matsui, M., Motomura, D., Karasawa, H., Fujikawa, T., Jiang, J., Komiya, Y., Takahashi, S.-I. & Taketo, M.M. (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc. Natl Acad. Sci. USA, 97, 9579-9584.
35. McBain, C.J. & Mayer, M.L. (1994) N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev., 74, 723-760.
36. Messer, W.S. Jr, Bohnett, M. & Stibbe, J. (1990) Evidence for a preferential involvement of M1 muscarinic receptors in representation memory. Neurosci. Lett., 116, 184-180.
37. Miyakawa, T., Yamada, M., Duttaroy, A. & Wess, J. (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the m1 muscarinic acetylcholine receptor. J. Neurosci., 21, 5239-5250.
38. Ohno, M., Yamamoto, T. & Watanabe, S. (1994) Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats. Brain Res., 650, 260-266.
39. Porter, A.C., Bymaster, F.P., DeLapp, N.W., Yamada, M., Wess, J., Hamilton, S.E., Nathanson, N.M. & Felder, C.C. (2002) M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Res., 944, 282-289.
40. Richards, M. & van Giersbergen, P.L.M. (1995) Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists. Br. J. Pharmacol., 114, 1241-1249.
41. Ringdahl, B., Roch, M. & Jenden, D.J. (1988) Tertiary 3- and 4-haloalkylamine analogues of oxotremorine as prodrugs of potent muscarinic agonists. J. Med. Chem., 31, 160-164.
42. Sanchez, C. & Meier, E. (1993) Central and peripheral mediation of hypothermia, tremor and salivation induced by muscarinic agonists in mice. Pharmacol. Toxicol., 72, 262-267.
43. Sarter, M. & Bruno, J.P. (1997) Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Brain Res. Rev., 23, 28-46.
44. Turski, W.A., Cavalheiro, E.A., Bortolotto, Z.A., Mello, L.M., Schwarz, M. & Turski, L. (1984) Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res., 321, 237-253.
45. Watson, E.L., Abel, P.W., DiJulio, D., Zeng, W., Makoid, M., Jacobson, K.L., Potter, L.T. & Dowd, F.J. (1996) Identification of muscarinic receptor subtypes in mouse parotid gland. Am. J. Physiol., 271, (Cell Biol), C905-C913.
46. Whitehouse, P.J., Price, D., I, Struble, R.G., Clark, A.W., Coyle, J.T. & Delong, M.R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basil forebrain. Science, 215, 1237-1239.
47. Yamada, M., Lamping, K.G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F.P., McKinzie, D.L., Felder, C.C., Deng, C.-X., Faraci, F.M. & Wess, J. (2001b) Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice. Proc. Natl Acad. Sci. USA, 98, 14096-14101.
48. Yamada, M., Miyakawa, T., Duttaroy, A., Yamanaka, A., Moriguchi, T., Makita, R., Ogawa, M., Chou, C.J., Xia, B., Crawley, J.N., Den Felder, C.C., C.-X. & Wess, J. (2001a) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature, 410, 207-212.